168
Participants
Start Date
March 31, 2010
Primary Completion Date
January 31, 2015
Study Completion Date
January 31, 2015
C-11 PiB
One time intravenous administration of 740 megabecquerel (MBq) of \[N-methyl-11C\]2-(4'-methylaminophenyl)-6-hydroxybenzothiazole (PiB) (range 370 - 740 MBq).
F-18 FDG
One time intravenous administration of 629 megabecquerel (MBq) of \[18-F\]-fluoro-deoxy-glucose (FDG) (range 555 - 740 MBq).
Mayo Clinic, Rochester
Lead Sponsor
Mayo Clinic
OTHER